ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,214Medicare Part D Prescriptions Filled, Including Refills
$445K Total Retail Price of All Prescriptions
128 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LEVOTHYROXINE SODIUM 376 294
OMEPRAZOLE 281 197
OXYCODONE HCL 279 186 S2
METOPROLOL TARTRATE 260 210
TRAMADOL HCL 220 155
SERTRALINE HCL 192 192
QUETIAPINE FUMARATE 188 169
CITALOPRAM HBR 180 144
AMLODIPINE BESYLATE 177 108
MIRTAZAPINE 146 113
FUROSEMIDE 144 133
GABAPENTIN 142 115
DONEPEZIL HCL 138 122
DIVALPROEX SODIUM 136 94
SIMVASTATIN 128 102
FAMOTIDINE 127 110
TRAZODONE HCL 125 83
RISPERIDONE 124 76
CLOZAPINE 124 48
WARFARIN SODIUM 123 77
NAMENDA 122 122
METFORMIN HCL 122 0
NOVOLIN N 121 121
GLIPIZIDE 111 88
RANITIDINE HCL 110 37
LISINOPRIL 105 70
METOCLOPRAMIDE HCL 100 61
TAMSULOSIN HCL 97 93
CARBIDOPA-LEVODOPA 97 74
LACTULOSE 96 48
LEVETIRACETAM 92 63
MORPHINE SULFATE 92 37 S2
OLANZAPINE 90 18
CELEBREX 83 69
FENOFIBRATE 82 62
ATORVASTATIN CALCIUM 80 38
SEROQUEL 78 67
ENALAPRIL MALEATE 75 48
TRIAMCINOLONE ACETONIDE 73 63
LIDODERM 72 72
HALOPERIDOL 69 57
ESCITALOPRAM OXALATE 69 50
DIVALPROEX SODIUM ER 64 27
HYDROCHLOROTHIAZIDE 63 55
MELOXICAM 63 36
NYSTOP 61 31
CEPHALEXIN 61 54
VENLAFAXINE HCL ER 60 0
CIPROFLOXACIN HCL 57 47
CLONIDINE HCL 50 24
POLYETHYLENE GLYCOL 3350 50 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.